KLSE (MYR): NOVAMSC (0026)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.215
Today's Change
+0.02 (10.26%)
Day's Change
0.185 - 0.23
Trading Volume
86,522,500
Market Cap
272 Million
NOSH
1,267 Million
Avg Volume (4 weeks)
29,238,505
4 Weeks Range
0.105 - 0.23
4 Weeks Price Volatility (%)
52 Weeks Range
0.09 - 0.23
52 Weeks Price Volatility (%)
Previous Close
0.195
Open
0.195
Bid
0.215 x 4,057,900
Ask
0.22 x 1,209,100
Day's Range
0.185 - 0.23
Trading Volume
86,522,500
Latest Quarter | Ann. Date
31-Mar-2024 [#4] | 29-May-2024
Next QR | Est. Ann. Date
30-Jun-2024 | 24-Aug-2024
T4Q P/E | EY
-43.92 | -2.28%
T4Q DY | Payout %
0.00% | 0.00%
T4Q NAPS | P/NAPS
0.02 | 8.63
T4Q NP Margin | ROE
-20.39% | -19.67%
2024-06-30
Sector: TECHNOLOGY
Sector: TECHNOLOGY
Subsector: SOFTWARE
Subsector: SOFTWARE
Description:
Nova MSC Bhd is an investment holding company. It is engaged in software research and development, and provision of e-business solutions through the sale of application software and professional services for software customization and implementation. Its segments include Malaysia and Singapore. The company's software products include Pavo, which is an e-Government software that facilities the online submission of application documents; Fornax, which is electronic plan check checking systems software that automates the process of checking and approving building plans and Avicenna, which is a fully integrated cloud-based system which takes care of the administrative needs.
https://www.youtube.com/watch?v=4tOvw7u1hPA How an AI Eye Test is Saving Lives from Heart Disease in Australia
2 weeks ago
Why so quiet here? No one seems to be excited about today's performance!!!!
Tomorrow another great show?
2 weeks ago
SELENA+ was cited recently by Deputy Prime Minister Mr Heng Swee Keat as one of key healthcare projects in Singapore's National AI Strategy.
On 5 March 2020, during the MOH Committee of Supply debate, SELENA+ was also cited as an example of an innovative technology to tackle healthcare challenges by Singapore’s Minister of Health Mr Gan Kim Yong, “One example we are already deploying is the Singapore Eye Lesion Analyser Plus (SELENA+). This is a deep-learning artificial intelligence software system which can detect three major eye conditions: diabetic eye disease, glaucoma and age-related macular degeneration. SELENA+ highlights areas with potential vision threatening eye disease and refers abnormal cases to human graders, allowing them to focus on the more complex cases. SELENA+ has proven to be more efficient in delivering fast and accurate results.”
2 weeks ago
I bought at 11sen, sold all on yesterday at 14.5sen, because I saw the purchasing power very weak, feel that it will drop back anytime soon. So I quickly take profit, and hope it can drop back to 11-12 sen.
But today3-4pm I saw it break 16 - 16.5sen, I feel this round it will go further, coz the buying power is very strong and very fierce, so I jump in again at 16sen and 16.5sen.
I am not familiar with this counter, hope it can continue to go up.
2 weeks ago
Hahaha, this counter always shoot up for short time and will drop back. Although I'm not agree with you that the price can sustain. I still wish you good luck
2 weeks ago
@ VerySmartInvestor, hopefully it won't drop back that far. With this AI invention and new investors, i think sky is the limit for this counter. I truly think it will go all the way....
2 weeks ago
have monitored this counter for quite some time ... business looks ok la, but this counter also got some traits familiar to those con-penny stock .. continuous ESOS and PP seems forever until over 1 billion Nosh olready!! and Revenue and NP will says it all...go figure, good luck guys towards your TP 20 cents.
2 weeks ago
@Tuapui, very quiet this time. Did you buy back? Don't fall in trap again. I still waiting for it to drops back.
1 week ago
Yup, agreed with messi.
This round Novamsc uptrend looks sustainable.
That why I sold at 14.5sen. and bought back again on 16-16.5sen.
Based on the transaction volume and gut feeling, I feel that anything below 20sen is just a step stone for it to leap higher to 25sen, 30sen or even 35sen (if market condition is good, sentiment is good, company got good news)
1 week ago
But please do take note this is a very risky counter.
And it is overvalue now.
If you want to buy, you are buying based on trend only, not base on fundamental.
Unless the company technology products really breakthrough and start generate 5-10mil profit per quarter, then only it will become a good fundamental buy.
1 week ago
I have this stock since 7 years ago. Lol. This time I believe can break 20c with this market condition. This business if having really consecutive positive QRs, limit up not a issue. Hopefully can see this day.
By the way, as same as Albukhary, it is definitely risky stock. I have sold some 0.09 at 20c. :) but I am still holding 0.085-0.09 range.
1 week ago
Step by step, climb up steadily.
Another financial quarter ending 30 June closing soon, hopefully showing some profit
3 days ago
NOVAMSC
What’s brewing, time to wake up
Novamsc has been in collection for so long and has embarked first journey since 12.5c. a wavering movement signify that collection has been made at few prices for next journey. A little bit on Nova. The company engaged in software research and development and provision of e-solutions through application software and customization.
with the AI and Datacentre mania, it is imminent Novamsc is ready to begin what they have prepared for. To recap, in January 2023 Novamsc has termed an MOU with Theta Edge Berhad to collaborate on Healthcare and public sector and applied Artificial Intelligence (A.I). This collaboration had materialised a join venture later in September 2023 with term of equity holding Theta 60% and NOVA 40%. This strategic partnering will benefit both parties in term of:
1. Providing e-government solution
2. IT solutions
3. Ready to deploy software
Aims to address key challenges faced by government agencies and businesses alike, paving the way for a seamless transition to a modern and technologically advanced ecosystem. The primary focus will be on providing Al based services such as "Building Information Modeling" which automate the building plan and design validation which is used by local councils to validate building plans submitted to these councils.
On August 2018, Novamsc completed acquisition of 42% equity interest in Eyris Pte Ltd which principally involved in managing research and experimental development on medical technologies. This in line with Nova’s strategy to introduce AI in industry.
On May 2020, the group incorporated a new company called DEX- Lab Pte Ltd (DEX-LAB) in Singapore to focus on development and marketing of AI product and services.
Major shareholder is non other than semiconductor tycoon, Mr Ooi Keng Thye (Frontkn Chairman) which hold 16.14% stake. Among others prominent Raden Corporation Sdn Bhd a member of the Negeri Sembilan royal family. Recent acquisition seen is Societe General Paris, the third largest bank of Paris.
Prospect of Novamsc group
NovaMSC has embraced a transformative growth strategy, focusing on four key pillars:
Healthcare, E-Government, Artificial Intelligence, and Robotics.
NovaMSC's software products:
1. Pavo, an e-Government software designed to streamline the online submission of application documents.
2. Fornax, a software system dedicated to electronic plan check procedures, automating the verification and approval processes for building plans.
3. Avicenna, a fully integrated cloud-based system that comprehensively addresses administrative requirements.
4. Vesalius, a web-based platform that supports the administrative and clinical function within a hospital
5. Dex-lab Pte Ltd, has achieved a significant milestone by creating DEXIE a highly advanced human-looking social robot tailored for the eldercare sector in Singapore.
6. EyScan, an intelligent deep learning system that performs automated retinal photo analysis, which was developed under EyRIS Pte Ltd ("EyRIS") has made remarkable progress with its Al-driven SELENA+ system, designed for the early detection of eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration
EyRIS is set to embark on a groundbreaking study in collaboration with Optometrist Warehouse a division of the Chemist Warehouse Group in Australia. This study will focus on evaluating the effectiveness of Artificial Intelligence ("Al") in screening diabetic retinopathy in the Australian context. As EyRIS continues to make strides in leveraging Al for healthcare, this partnership signifies a significant step forward in addressing critical eye health concerns through cutting-edge technology.
Through the above-mentioned activities, the Group has been intensifying their efforts to drive sales and expand their market presence.
Rumours been going around that another significant figure will emerge as stakeholder. With the emerging shareholder soon many other hundred million value contracts will flow in to Novamsc
Regards,
Lily of the valley
2 days ago
Weekly & daily chart showing positive uptrend momentum.
Steadily climbing up the volume leaders chart.
Good luck!!!
2 days ago
Good closing... Everybody should have a happy weekend this week.
Next week is July, it will be a great start for NOVAMSC... 25sen, 35sen and 50sen is coming.
1 day ago
11,886,800 shares from PA conversion to be listed on Monday.
Might cause a slight price dip and present another opportunity to hop on the train.
Charts still uptrend.
Good luck!!!
21 hours ago
this announcement is on Friday before open at 230pm.
the price went up from 19.5 to 23 instead.
16 hours ago
big player have / will continue coming for very specific - AI technology uses a Deep Learning System (DLS)
SELENA+ already in motion and getting better, evolved faster than we expected.
this will / might be the highlight and new finding in AI for healthcare segment.
it very very positive.
last Q improved, next Q look positive.
I am in long with this one.
4 hours ago
I have written my opinion on NOVAMSC-PA at date: 2021-03-08 20:11
“Below are examples of a few issues of this 1sen bargain.
NOVAMSC-PA at 8sen around 700% gain off this 1sen issuance.” beside others ICPS subscription of 1 sen. It seems NOVAMSC-PA is doing so well, will others follow??
Link: https://klse.i3investor.com/web/blog/detail/BLee_AGES/2021-03-08-story-h1542067522-AGES_ICULS_The_30_Billion_of_1sen_bargain
How much $ Capital increased for this conversion during the last 6 months? The value increase is MYR2,937,809.99
Listing Date: 18 Dec 2023
Capital: Malaysian Ringgit (MYR) 115,603,726.330
NOSH: 1,193,889,250
Additional Listing Link: https://www.klsescreener.com/v2/announcements/view/6042057
Listing Date: 01 Jul 2024
Capital: Malaysian Ringgit (MYR) 118,541,536.320
NOSH: 1,278,929,583
Additional Listing Link:
https://www.klsescreener.com/v2/announcements/view/7213461
It is obvious conversion of ICPS is advantageous financially for the company; therefore chances of traded price will increase..
Note: I am very much in AGES-PA, Fintec-PA and Focus-PA; sharing Advantages of ICPS only. This write-up is NOT a recommendation to buy the above mentioned counters as only recently made some gain..Happy Trading and TradeAtYourOwnRisk
2 hours ago
stncws
mr ooi buys more, angel investment believe this stock is good for future..
3 weeks ago